High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.6M
$3,598,635
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-25
$324,882
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-25 | $324,882 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-18
$386,997
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-18 | $386,997 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-17
$994,093
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-17 | $994,093 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-11
$806,213
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-11 | $806,213 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 SellΔOwn -12.9%
2025-11-17
$1,086,450Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 SellΔOwn -12.9%
|
2025-11-17 | $1,086,450Large | S | Form 4 |